X4 Pharmaceuticals, Inc reports

Location
61 North Beacon Street, 4 Th Floor, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/13/2024, 09:04 AM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q Nov 13, 2024 Sep 30, 2024
8-K Report | Data 8-K Nov 13, 2024 Nov 13, 2024
8-K Report | Data 8-K Nov 13, 2024 Nov 13, 2024
SC 13G/A Report Nov 12, 2024
SC 13G Report Nov 8, 2024
SC 13G/A Report Nov 4, 2024
SC 13G Report Oct 22, 2024
8-K Report | Data 8-K Aug 16, 2024 Aug 13, 2024
8-K Report | Data 8-K Aug 9, 2024 Aug 8, 2024
10-Q Report | Data 10-Q Aug 8, 2024 Jun 30, 2024
8-K Report | Data 8-K Aug 8, 2024 Aug 8, 2024
8-K Report | Data 8-K Jul 19, 2024 Jul 19, 2024
8-K Report | Data 8-K Jun 27, 2024 Jun 27, 2024
8-K Report | Data 8-K Jun 11, 2024 Jun 10, 2024
8-K Report | Data 8-K May 22, 2024 May 22, 2024
8-K Report | Data 8-K May 9, 2024 May 8, 2024
10-Q Report | Data 10-Q May 7, 2024 Mar 31, 2024
8-K Report | Data 8-K May 7, 2024 May 7, 2024
8-K Report | Data 8-K Apr 29, 2024 Apr 29, 2024
8-K Report | Data 8-K Apr 29, 2024 Apr 29, 2024
8-K Report | Data 8-K Apr 5, 2024 Apr 5, 2024
8-K Report | Data 8-K Apr 1, 2024 Apr 1, 2024
10-K Report | Data 10-K Mar 21, 2024 Dec 31, 2023
8-K Report | Data 8-K Mar 21, 2024 Mar 21, 2024
SC 13G/A Report AMENDMENT NO. 4 Feb 14, 2024
SC 13G Report Feb 14, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 13, 2024
SC 13G/A Report Feb 7, 2024
SC 13G Report Jan 31, 2024
SC 13G/A Report Jan 16, 2024
8-K Report | Data 8-K Jan 8, 2024 Jan 8, 2024
SC 13G/A Report X4 PHARMACEUTICALS, INC. Jan 8, 2024
8-K Report | Data 8-K Nov 27, 2023 Nov 27, 2023
8-K Report | Data 8-K Nov 14, 2023 Nov 13, 2023
10-Q Report | Data 10-Q Nov 9, 2023 Sep 30, 2023
8-K Report | Data 8-K Nov 9, 2023 Nov 9, 2023
8-K Report | Data 8-K Oct 31, 2023 Oct 31, 2023
8-K Report | Data 8-K Oct 18, 2023 Oct 16, 2023
8-K Report | Data 8-K Sep 5, 2023 Sep 5, 2023
10-Q Report | Data 10-Q Aug 10, 2023 Jun 30, 2023
8-K Report | Data 8-K Aug 10, 2023 Aug 10, 2023
8-K Report | Data 8-K Aug 3, 2023 Aug 2, 2023
SC 13G Report Jun 16, 2023
8-K Report | Data 8-K Jun 15, 2023 Jun 13, 2023
8-K Report | Data 8-K Jun 1, 2023 Jun 1, 2023
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 May 26, 2023
8-K Report | Data 8-K May 16, 2023 May 15, 2023
10-Q Report | Data 10-Q May 4, 2023 Mar 31, 2023
8-K Report | Data 8-K May 4, 2023 May 4, 2023
8-K Report | Data 8-K May 4, 2023 May 4, 2023
8-K Report | Data 8-K May 4, 2023 May 4, 2023
8-K Report | Data 8-K Mar 21, 2023 Mar 21, 2023
10-K Report | Data 10-K Mar 21, 2023 Dec 31, 2022
8-K Report | Data 8-K Mar 21, 2023 Mar 21, 2023
8-K Report | Data 8-K Mar 10, 2023 Mar 10, 2023
SC 13G/A Report AMENDMENT NO. 3 Feb 14, 2023
SC 13G/A Report SCHEDULE 13G/A, AMENDMENT #2 Feb 14, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report AMENDMENT NO. 4 TO THE SCHEDULE 13G Feb 14, 2023
SC 13G Report X4 PHARMACEUTICALS, INC. Jan 13, 2023
8-K Report | Data 8-K Jan 6, 2023 Jan 6, 2023
8-K Report | Data 8-K Jan 5, 2023 Jan 5, 2023
8-K Report | Data 8-K Dec 23, 2022 Dec 20, 2022
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 Dec 20, 2022
8-K Report | Data 8-K Dec 9, 2022 Dec 6, 2022
8-K Report | Data 8-K Nov 29, 2022 Nov 29, 2022
8-K Report | Data 8-K Nov 9, 2022 Nov 7, 2022
10-Q Report | Data 10-Q Nov 3, 2022 Sep 30, 2022
8-K Report | Data 8-K Nov 3, 2022 Nov 3, 2022
8-K Report | Data 8-K Oct 4, 2022 Oct 4, 2022
8-K Report | Data 8-K Sep 27, 2022 Sep 27, 2022
8-K Report | Data 8-K Sep 1, 2022 Sep 1, 2022
8-K Report | Data 8-K Aug 5, 2022 Aug 5, 2022
10-Q Report | Data 10-Q Aug 4, 2022 Jun 30, 2022
8-K Report | Data 8-K Aug 4, 2022 Aug 4, 2022
8-K Report | Data 8-K Jul 29, 2022 Jul 25, 2022
SC 13D Report GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 Jul 19, 2022
8-K Report | Data 8-K Jul 1, 2022 Jun 30, 2022
8-K Report | Data 8-K Jun 7, 2022 Jun 6, 2022
8-K Report | Data 8-K May 20, 2022 May 20, 2022
10-Q Report | Data 10-Q May 12, 2022 Mar 31, 2022
8-K Report | Data 8-K May 12, 2022 May 12, 2022
10-K Report | Data 10-K Mar 17, 2022 Dec 31, 2021
8-K Report | Data 8-K Mar 17, 2022 Mar 17, 2022
8-K Report | Data 8-K Mar 3, 2022 Mar 3, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report SCHEDULE 13G (AMENDMENT NO. 1) Feb 14, 2022
SC 13G/A Report X4 PHARMACEUTICALS, INC Feb 14, 2022
SC 13G/A Report AMENDMENT NO. 3 TO THE SCHEDULE 13G Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report AMENDMENT NO. 2 Feb 11, 2022
SC 13G/A Report Feb 11, 2022
8-K Report | Data 8-K Feb 9, 2022 Feb 9, 2022
8-K/A Report | Data 8-K/A Jan 26, 2022 Jan 25, 2022
8-K Report | Data 8-K Jan 25, 2022 Jan 25, 2022
SC 13G Report SC 13G Jan 19, 2022
8-K Report | Data 8-K Jan 14, 2022 Jan 14, 2022
8-K Report | Data 8-K Jan 14, 2022 Jan 13, 2022
8-K Report | Data 8-K Dec 13, 2021 Dec 13, 2021
SC 13G Report SCHEDULE 13G Nov 17, 2021
8-K Report | Data 8-K Nov 15, 2021 Nov 15, 2021
8-K Report | Data 8-K Nov 12, 2021 Nov 11, 2021
8-K Report | Data 8-K Nov 5, 2021 Nov 5, 2021
10-Q Report | Data 10-Q Nov 4, 2021 Sep 30, 2021
8-K Report | Data 8-K Nov 4, 2021 Nov 4, 2021
8-K Report | Data 8-K Oct 19, 2021 Oct 14, 2021
8-K Report | Data 8-K Sep 10, 2021 Sep 10, 2021
8-K Report | Data 8-K Aug 6, 2021 Aug 6, 2021
10-Q Report | Data 10-Q Aug 3, 2021 Jun 30, 2021
8-K Report | Data 8-K Aug 3, 2021 Aug 3, 2021
8-K Report | Data 8-K Jul 23, 2021 Jul 20, 2021
8-K Report | Data 8-K Jul 15, 2021 Jul 15, 2021
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP Jun 29, 2021
8-K Report | Data 8-K Jun 28, 2021 Jun 28, 2021
8-K Report | Data 8-K Jun 11, 2021 Jun 11, 2021
8-K Report | Data 8-K Jun 7, 2021 Jun 7, 2021
SC 13G/A Report May 7, 2021
8-K Report | Data 8-K May 6, 2021 May 6, 2021
10-Q Report | Data 10-Q May 6, 2021 Mar 31, 2021
8-K Report | Data 8-K Apr 9, 2021 Apr 9, 2021
SC 13G/A Report SC 13G/A Apr 8, 2021
SC 13G/A Report AMENDMENT NO. 1 Mar 25, 2021
10-K Report | Data 10-K Mar 19, 2021 Dec 31, 2020
8-K Report | Data 8-K Mar 19, 2021 Mar 18, 2021
8-K Report | Data 8-K Mar 4, 2021 Mar 4, 2021
SC 13G/A Report SC 13G/A Feb 16, 2021
SC 13G/A Report SC 13G/A Feb 16, 2021
SC 13G/A Report AMENDMENT NO. 2 TO THE SCHEDULE 13G Feb 16, 2021
SC 13G/A Report Feb 16, 2021
SC 13G/A Report Feb 12, 2021
SC 13G Report Feb 2, 2021
8-K Report | Data 8-K Jan 8, 2021 Jan 8, 2021
SC 13G Report SC 13G Dec 30, 2020
8-K Report | Data 8-K Dec 23, 2020 Dec 21, 2020
10-Q Report | Data 10-Q Nov 5, 2020 Sep 30, 2020
8-K Report | Data 8-K Nov 5, 2020 Nov 5, 2020
8-K Report | Data 8-K Oct 16, 2020 Oct 14, 2020
8-K Report | Data 8-K Oct 7, 2020 Oct 7, 2020
8-K Report | Data 8-K Oct 1, 2020 Sep 25, 2020
8-K Report | Data 8-K Sep 11, 2020 Sep 11, 2020
SC 13G/A Report Sep 10, 2020
10-Q Report | Data 10-Q Aug 4, 2020 Jun 30, 2020
8-K Report 8-K Jul 30, 2020 Jul 29, 2020
8-K Report 8-K Jun 11, 2020 Jun 10, 2020
10-Q Report | Data 10-Q May 7, 2020 Mar 31, 2020
8-K Report 8-K May 7, 2020 May 6, 2020
8-K Report 8-K Mar 20, 2020 Mar 18, 2020
8-K Report 8-K Mar 17, 2020 Mar 13, 2020
10-K Report | Data 10-K Mar 12, 2020 Dec 31, 2019
8-K Report 8-K Mar 12, 2020 Mar 6, 2020
SC 13G/A Report AMENDMENT NO. 1 TO THE SCHEDULE 13G Feb 14, 2020
SC 13G Report SCHEDULE 13G Feb 14, 2020
SC 13G/A Report Feb 14, 2020
SC 13G/A Report Feb 14, 2020
8-K Report 8-K Feb 13, 2020 Feb 10, 2020
SC 13G/A Report Feb 13, 2020
8-K Report 8-K Jan 10, 2020 Jan 9, 2020
SC 13G Report Dec 17, 2019
SC 13G Report SC 13G Dec 9, 2019
SC 13G/A Report Dec 3, 2019
8-K Report 8-K Nov 27, 2019 Nov 25, 2019
8-K Report 8-K Nov 14, 2019 Nov 14, 2019
10-Q Report | Data 10-Q Nov 7, 2019 Sep 30, 2019
8-K Report 8-K Nov 7, 2019 Nov 7, 2019
8-K/A Report 8-K/A Oct 18, 2019 Sep 18, 2019
8-K Report 8-K Oct 4, 2019 Oct 3, 2019
8-K Report 8-K Sep 30, 2019 Sep 30, 2019
8-K Report 8-K Sep 20, 2019 Sep 18, 2019
8-K Report 8-K Aug 9, 2019 Aug 9, 2019
10-Q Report | Data 10-Q Aug 7, 2019 Jun 30, 2019
SC 13D/A Report SC 13D/A Jul 17, 2019
8-K Report 8-K Jun 28, 2019 Jun 27, 2019
8-K Report 8-K Jun 26, 2019 Jun 26, 2019
8-K Report 8-K Jun 19, 2019 Jun 17, 2019
SC 13D/A Report NEW ENTERPRISE ASSOCIATES 16, L.P. - X4 PHARMACEUTICALS, INC. 13D/A1 May 28, 2019
8-K/A Report 8-K/A May 17, 2019 Mar 29, 2019
10-Q Report | Data 10-Q May 15, 2019 Mar 31, 2019
8-K/A Report 8-K/A May 13, 2019 Mar 11, 2019
SC 13G Report May 10, 2019
SC 13D/A Report SC 13D/A Apr 26, 2019
SC 13G Report THE SCHEDULE 13G Apr 23, 2019
SC 13G Report Apr 22, 2019
SC 13G Report SCHEDULE 13G Apr 19, 2019
SC 13G Report Apr 16, 2019
8-K Report 8-K Apr 15, 2019 Apr 12, 2019
8-K Report 8-K Apr 12, 2019 Apr 11, 2019
8-K Report FORM 8-K Apr 11, 2019 Apr 11, 2019
8-K/A Report 8-K/A Apr 3, 2019 Mar 11, 2019
8-K Report FORM 8-K Apr 2, 2019 Mar 29, 2019
8-K Report 8-K Apr 1, 2019 Apr 1, 2019
SC 13D Report SC 13D Mar 22, 2019
SC 13D/A Report AMENDMENT NO. 2 Mar 19, 2019
SC 13G Report Mar 15, 2019
8-K Report 8-K Mar 13, 2019 Mar 11, 2019
10-K Report | Data 10-K Mar 11, 2019 Dec 31, 2018
8-K Report 8-K Mar 8, 2019 Mar 8, 2019
8-K Report 8-K Mar 1, 2019 Feb 25, 2019
8-K Report 8-K Feb 8, 2019 Feb 4, 2019
8-K Report 8-K Jan 16, 2019 Jan 11, 2019
8-K Report 8-K Dec 20, 2018 Dec 12, 2018
SC 13D Report SCHEDULE 13D Dec 6, 2018
8-K Report 8-K Nov 27, 2018 Nov 27, 2018
8-K Report 8-K Nov 27, 2018 Nov 26, 2018
10-Q Report | Data 10-Q Nov 9, 2018 Sep 30, 2018
8-K Report 8-K Nov 9, 2018 Nov 9, 2018
SC 13G/A Report Oct 10, 2018
10-Q Report | Data 10-Q Aug 13, 2018 Jun 30, 2018
8-K Report 8-K Aug 13, 2018 Aug 13, 2018
SC 13G/A Report Aug 10, 2018
8-K Report FORM 8-K Jun 28, 2018 Jun 28, 2018
8-K Report 8-K Jun 12, 2018 Jun 6, 2018
8-K Report 8-K Jun 7, 2018 Jun 5, 2018
10-Q Report | Data 10-Q May 10, 2018 Mar 31, 2018
8-K Report 8-K May 10, 2018 May 10, 2018
10-K Report 10-K Mar 9, 2018 Dec 31, 2017
8-K Report 8-K Mar 9, 2018 Mar 9, 2018
SC 13D Report SC 13D Feb 14, 2018
SC 13G Report Feb 13, 2018
SC 13G/A Report Feb 13, 2018
SC 13D/A Report AMENDMENT NO. 1 Jan 26, 2018
SC 13G Report Dec 11, 2017
SC 13D Report SCHEDULE 13D Nov 30, 2017
SC 13D Report SC 13D Nov 29, 2017
SC 13D Report NEW ENTERPRISE ASSOCIATES 16, L.P. - ARSANIS, INC. 13D Nov 29, 2017
8-K Report 8-K Nov 20, 2017 Nov 20, 2017